ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Histocompatibility"

  • 2018 American Transplant Congress

    Flow DSA-XM: Better Crossmatch or Just Different Problems?

    P. Kimball, F. McDougan.

    Surgery, VCUHealth Systems, Richmond, VA.

    Background. Despite the positive impact of flow crossmatching(FCXM) upon alloantibody detection, its inability to distinguish anti-Class I from Class II or non-HLA from HLA-antibodies remain…
  • 2018 American Transplant Congress

    Shortened Cold Ischemia Time and Reduced Incidence of Delayed Graft Function for Kidney Transplants through Enhanced Tissue Compatibility Testing

    I. Helanterä,1 T. Saarinen,2 J. Peräsaari,2 M. Lempinen,1 J. Lauronen.2

    1Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland; 2Histocompatibility Laboratory, Finnish Red Cross Blood Service, Helsinki, Finland.

    A. HLA-typing and prospective leukocyte cross-matching needed for deceased donor kidney transplantation (kTX) may delay the onset of surgery. We compared cold ischemia times (CIT)…
  • 2018 American Transplant Congress

    Selection and Stratification of Anti-HLA-A and HLA-B Sensitized Patients in Pig-to-Human Xenotransplantation

    G. Martens,1 J. Ladowski,1 J. Butler,2 L. Reyes,1 M. Tector,1 A. Tector.1

    1University of Alabama at Birmingham, Birmingham, AL; 2Indiana University School of Medicine, Indianapolis, IN.

    Introduction: Patients with anti-HLA-A and –B antibodies are difficult to match and represent a possible population for inclusion in pig-to-human xenotransplantation clinical trials. Donor specific…
  • 2018 American Transplant Congress

    Increasing the Donor Pool for Highly Sensitized Patients with Allele Specific Antibodies: Optimizing the Virtual Crossmatch (vXM)

    A. Zhang,1 Z. Zaky,2 J. Africa,3 D. Good,1 R. Bray,4 H. Gebel.4

    1Allogen Laboratories, Cleveland Clinic, Cleveland; 2Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland; 3Transplant Surgery, Charleston Area Medical Center, Charleston; 4Pathology & Laboratory Medicine, Emory University, Atlanta.

    Background:Since implementation of the current Kidney Allocation System, highly sensitized patients with 98-100% cPRA (HSPs) are receiving ~10% of deceased donor kidneys compared to <2%…
  • 2017 American Transplant Congress

    Accelerated Rejection of Secondary Third Party Allografts in Older Recipients Is Facilitated by an Augmented Innate Immune Response.

    T. Heinbokel, K. Minami, A. Elkhal, S. Tullius.

    Transplant Surgery Research Laboratory and Division of Transplant Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Accumulating evidence acknowledges the central relevance of aging and chronic antigen exposure in shaping the balance of innate and adaptive immunity. Here, we assessed whether…
  • 2017 American Transplant Congress

    Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.

    C. Jacquelinet,1 B. Audry,1 C. Antoine,1 C. Suberbielle,2 D. Glotz,2 A. Tambur.3

    1Agence de la Biomedecine, Saint Denis, France; 2Saint Louis Hospital, Paris, France; 3Northwestern University, Chicago

    To increase the likelihood of finding a compatible donor, kidney allocation systems prioritize highly sensitized patients to counterbalance the impact of HLA allo-sensitization and preclude…
  • 2017 American Transplant Congress

    MHC Class II-Peptide Complexes Displayed on Activated T Cells Guide Treg Suppression.

    M. Fryer, S. Junius, S. Germana, L. Turka, C. LeGuern.

    Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA

    Background: Regulatory T cell (Tregs) therapy remains a promising strategy for minimizing immunosuppression and extending allograft survival. Although Treg suppression requires initial activation through cell…
  • 2017 American Transplant Congress

    Effects of New KPD Histocompatibility Policy on Refusal Rate and Transplants.

    R. Leishman,1 M. Aeder,2 M. Leffell,3 C. Murphey,4 N. Reinsmoen,5 S. Saidman,6 T. Sandholm,7 A. Toll,1 A. Harper,1 N. Turgeon.8

    1UNOS, Richmond, VA; 2Univ Hosp Med Ctr, Cleveland, OH; 3Johns Hopkins Univ, Baltimore, MD; 4SW Immunodiagnostics, San Antonio, TX; 5Cedars-Sinai Health, Los Angeles, CA; 6Mass Gen Hosp, Boston, MA; 7Carnegie Mellon Univ, Pittsburgh, PA; 8Emory Univ, Atlanta, GA

    Background: Transplant centers commonly refuse kidney paired donation (KPD) match offers due to unacceptable crossmatch (XM). To reduce XM refusals a new OPTN KPD histocompatibility…
  • 2017 American Transplant Congress

    A Novel Computational HLA Matching Algorithm for Improving Donor-Recipient Histocompatibility and Graft Outcomes After Kidney Transplantation.

    V. Kosmoliaptsis,1 D. Mallon,1 S. Fuggle,2 R. Johnson,2 C. Watson,1 J. Bradley,1 C. Taylor.1

    1Department of Surgery, University of Cambridge, Cambridge, United Kingdom; 2NHS Blood and Transplant, Bristol, United Kingdom

    Introduction: Human Leukocyte Antigen (HLA) matching is a central objective of kidney allocation policies, but current assessment of histocompatibility is inadequate. Building on our previous…
  • 2017 American Transplant Congress

    HLA-DPA1 and HLA-DPB1 Frequencies in the US Populations.

    Z. Du, J. Patel, C. Braun, B. Norton.

    Pathology, Loyola University Medical Center, Maywood, IL

    Aim: HLA-DP antibodies can elicit positive crossmatches and be detrimental in organ transplantation. Although HLA-DP unacceptable antigens can be input in the UNOS database, they…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences